Nicklas Pfanzelter Learning Objectives:
- Articulate the role of radical surgery in managing carcinoma in situ and muscle invasive bladder cancer
- Define the multiple roles of checkpoint inhibitors in managing urothelial carcinoma
- Describe the efficacy and toxicities of novel agents used in managing advanced urothelial carcinoma
Norm Smith Learning Objectives:
- Define important surgical benchmarks of radical cystectomy for bladder cancer
- Describe the management of high-risk non-muscle invasive bladder cancer
- Verbalize the risks and benefits of open versus robotic radical cystectomy
Session date:
11/06/2020 - 8:00am to 9:00am CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Nicklas Pfanzelter, MD; Norm Smith, MD